| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 06/09/2004 | EP1425407A2 Enzymatic resolution of t-butyl taxane derivatives |
| 06/09/2004 | CN1502614A Intermediate for priparing taxanes derivative |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1152870C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
| 06/08/2004 | CA2099783C (2r, 3s)-.beta.-phenylisoserine and its salts, preparation and use |
| 06/08/2004 | CA2091002C Taxane derivatives, their preparation and use in oncology |
| 06/02/2004 | EP1423108A1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | CN1500780A (meth)Acrylic compound having an oxetanyl group and liquid crystal film produced by using the same |
| 06/01/2004 | US6743927 Process for enantioselectively producing the (r)-delta-lactone |
| 05/26/2004 | EP1339703B1 A process for the preparation of paclitaxel |
| 05/25/2004 | CA2186916C Process for preparing 7-trialkylsilyl baccatin iii |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2003035634A8 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097744 Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes |
| 05/20/2004 | US20040097579 Taxane formulations |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | CN1150179C Process for islation of 10-deacetyl baccatin III from recoverbly part of plant of I(TAXUS) species |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1150149C Method for synthesis of taxanes |
| 05/18/2004 | US6737534 Using 10-deacetylbaccatine iii easily recovered in large amounts from taxus baccata leaves as starting material |
| 05/18/2004 | US6737254 Supercritical extraction of taxanes |
| 05/13/2004 | US20040092453 Synergistic antineoplastic effect; side effect reduction |
| 05/12/2004 | EP1417193A1 Efficient process for the production of 10-dab iii by selective hydrazinolysis of various taxanes |
| 05/12/2004 | EP0918764B1 Method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
| 05/11/2004 | US6734314 Preparation of orlistat and orlistat crystalline forms |
| 05/06/2004 | WO2004037211A2 Taxane metabolites |
| 05/06/2004 | US20040087759 Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed mono-substituted fluorinated oxetane monomers |
| 05/06/2004 | US20040087649 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |
| 05/06/2004 | EP1206461B1 Process for the preparation of a paclitaxel c-4 methyl carbonate analog |
| 05/05/2004 | CN1148364C Process for extraction and purification of paclitaxel from natural sources |
| 05/05/2004 | CN1148363C C-7 metal alkoxides of baccatin III |
| 05/04/2004 | US6730782 Carbamoyl substituted β-lactams |
| 04/28/2004 | CN1491947A C10 ester carbonate substituted taxadane |
| 04/28/2004 | CN1491946A C 10 ester substituted taxadane |
| 04/27/2004 | US6727369 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups |
| 04/27/2004 | CA2111898C Process for manufacturing l-(-)-carnitine from a waste product having opposite configuration |
| 04/22/2004 | WO2004033442A2 Novel taxanes and methods related to use and preparation thereof |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/21/2004 | EP1410448A1 Novel photostructurable organic semiconductor materials |
| 04/15/2004 | US20040073048 Antitumor agents; anticancer agents; leukemia therapy; using metal alkoxide |
| 04/15/2004 | US20040073047 Preparation of substituted isoserine esters using beta-lactams and metal or ammonium alkoxides |
| 04/15/2004 | US20040072872 C10 ester substituted taxanes |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/14/2004 | EP1406869A1 Taxol enhancer compounds |
| 04/13/2004 | CA2365298C Quaternary ammonium and waterproofing/preservative compositions |
| 04/07/2004 | EP1405850A1 (Meth)acrylic compound having an oxetanyl group and liquid crystal film produced by using the same |
| 04/07/2004 | CN1144798C Process for producing oxetane |
| 04/06/2004 | CA2365054C Quaternary ammonium and waterproofing/preservative compositions |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004026230A2 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063977 Filtering by liquid column chromatography, enriching by precipitation and crystallization, dissolving in polar organic solvent mixture of alcohol and non-alcohol solvent |
| 04/01/2004 | US20040063976 Conversion 9-dihydro-13-acetylbaccatin iii into 10-deacetylbaccatin iii |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040062810 Removal blockage in blood vessels; mixture of angiogenesis inhibitor and polymer |
| 03/31/2004 | EP1403261A1 Conversion of 9-dihydro-13-acetylbaccatin III into 10-deacetylbaccatin III |
| 03/31/2004 | CN1486306A Isolation of taxanes |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/25/2004 | WO2004024706A2 Taxane derivatives functionalized at the 14- position and a process for the preparation thereof |
| 03/24/2004 | EP1399149A2 Taxane prodrugs |
| 03/23/2004 | US6710206 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof |
| 03/23/2004 | US6710191 9β-hydroxytetracyclic taxanes |
| 03/18/2004 | US20040054152 Materials that can be structured, method for producing the same and their use |
| 03/18/2004 | US20040052967 Actinic ray curable composition, actinic ray curable ink, image forming method, and ink jet recording apparatus |
| 03/17/2004 | EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 03/17/2004 | CN1142163C Process for separating and purifying ebormycine from fermented myxobacterium liquid |
| 03/16/2004 | US6706896 Process for selective derivatization of taxanes |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049060 Process for the preparation of paclitaxel |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/03/2004 | EP1392669A1 Chromatographic separation method of paclitaxel and cephalomannin |
| 03/03/2004 | EP1053345B1 Method for producing baccatin |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | CA2210924C Paclitaxel analogs, preparation and use as antitumor agents |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/25/2004 | EP1391459A1 Process for the preparation of a paclitaxel C-4 methyl carbonate analog and intermediates |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/25/2004 | EP1105380B1 Process for the preparation of c-4 deacetyltaxanes |
| 02/25/2004 | CN1478091A Process for preparation of taxan derivatives |
| 02/24/2004 | CA2150944C New taxoids; process for preparing the same and pharmaceutical compositions containing them |
| 02/19/2004 | WO2004014960A2 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 02/19/2004 | US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 02/18/2004 | EP1389197A1 Two-step conversion of protected taxane ester to paclitaxel |
| 02/18/2004 | EP1389196A1 Three-step conversion of protected taxane ester to paclitaxel |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/17/2004 | CA2214319C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 02/12/2004 | WO2004013096A2 Methods and compositions for converting taxane amides to paclitaxel or other taxanes |
| 02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |